Abstract:Zi-Qi Li, &ast Guo-Song Zhang, &ast Ri-Qun Liu, Shu-Yuan Shuai, Peng-Yi Hu, Qin Zheng, Shu-Hua Xiao Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, 330004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Peng-Yi Hu; Qin Zheng, Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, 330004, People's Republic of China, Tel/Fax +86 0791 87118658, Email ; Background: Ligustilide (LIG) and n-butylphthalide (NBP) have neuroprotective effects in cerebral ischemia; however, their roles in gliomas are not well-known.This study aimed to explore the anti-glioma effects of LIG and NBP individually and the synergistic effects of temozolomide (TMZ) via the PI3K/Akt Signaling Pathway. Materials and Methods: Cytotoxicity of LIG and NBP alone and in combination with TMZ in U251 cells was determined using the CCk-8. The effect of compounds alone or in combination on cell migration was detected using the wound healing assay, and the invasion was evaluated by transwell assays, respectively. Cell apoptosis was quantified by flow cytometry and the changed expressions of proteins were detected by Western blotting. Results: The results showed that LIG and NBP significantly inhibited the growth of U251 cells at concentrations of 4– 10 μg/mL and 1.5– 6 μg/mL in a dose-dependent manner ( p < 0.05, p < 0.01). The combination of 20 μg/mL TMZ with LIG in the concentration range of 4– 10 μg/mL or with NBP of 0.5– 6 μg/mlachieved synergistic effect towardsU251 cells. LIG and NBP, alone or in combination with TMZ, markedly inhibited cell invasion ( p < 0.001) and enhanced apoptosis ( p < 0.05). The combination of TMZ with LIG or NBP markedly inhibited cell migration ( p < 0.001). Western blot analysis showed that LIG, NBP, and TMZ, alone and in combination, significantly decreased the expression of Bcl-2, p-PI3K, and p-Akt, and increased the expression of Bax. Conclusion: Both LIG and NBP exert anti-glioma effects on their own through the PI3K/Akt pathway and enhance TMZ-mediated anti-glioma efficiency via the same pathway. Keywords: ligustilide, n-butylphthalide, glioma, synergistic effect, PI3K/Akt signaling pathway Graphical Glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a median survival of less than one year. 1 In the past 30 years, the incidence of glioma has been increasing at a rate of 1–2% per year. 2 Current approaches to therapy include surgery, radiotherapy, and chemotherapy, as well as emerging gene therapy and immunotherapy in recent years; however, the results are unsatisfactory. 3 Temozolomide (TMZ) is an oral alkylating agent and has been widely applied as an effective first-line chemotherapeutic agent for the treatment of glioma patients. 4 However, TMZ resistance is one of the main reasons for glioma treatment failure. Drug combinations are one of the effective means to alleviate drug resistance and improve therapeutic effect of glioma, 5 such as the combination of TMZ with an inhibitor of histone methyltransferase G9a BIX01294, 6 and the combination of TMZ with a prototype cyclooxygenase (COX-2) inhibitor NS-398. 7 The mechanism of the resistance to TMZ is various within the same tumor, and therefore it is a challenge to select which drug is compatible with TMZ. Chuanxiong ( Ligusticum chuanxiong Hort., Umbelliferae), a commonly used Chinese medicinal herb with hemodynamic and analgesic effects, has also been used in traditional Chinese medicine compound prescriptions to treat brain tumors, such as the Wenyang Tongqiao decoction, 8 JiuweiTongqiao decoction, 9 Naoliu power, 10 XuefuZhuyu decoction. 11 The essential oil of chuanxionginhibited glioma angiogenesis, cell migration, and invasion via the EGFR/VEGF-A signaling pathway. 12 Our previous research also showed that chuanxiong essential oil could enhanceTMZ-induced anti-cancer efficiency in vivo. 13 As the largest proportion of chuanxiong essential oil, phthalide contains a large amount of ligustilide (LIG) and n-butylphthalide (NBP); 14 its chemical structure is shown in Figure 1. LIG significantly reduced T98G cells' migration, 15 inhibited the secretion of vascular endothelial growth factor A (VEGFA) from prostate cancer-related fibroblasts. 16 Interestingly, LIG showed little cytotoxicity to normal hepatocytes but restrained cell proliferation and -Abstract Truncated-

Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism

Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion

Ligustilide Inhibits the Activation of Cancer-Associated Fibroblasts

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

Effects of Ligustilide on Tumor Growth and Immune Function in Institute of Cancer Research Mice

Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer

Ginkgolide B Inhibits Lung Cancer Cells Promotion Via Beclin-1-dependent Autophagy

Ligustilide Induces Apoptosis and Reduces Proliferation in Human Bladder Cancer Cells by NFκB1 and Mitochondria Pathway

Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma

Lycorine Suppresses Non-Small-Cell Lung Cancer Progression Through Activating STING Pathway and Stimulating an Antitumor Immune Response

P3.02c-004 SBI0206965, a Novel Inhibitor of Ulk1, Suppresses Non-Small Cell Lung Cancer Cell Growth Via Modulating Both Autophagy and Apoptosis Pathways: Topic: Targeted Therapy

Proteomic analysis reveals the molecular mechanism of Astragaloside in the treatment of non-small cell lung cancer by inducing apoptosis

Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion

Lidocaine Inhibits the Proliferation of Lung Cancer by Regulating the Expression of Golt1a

The Local Anaesthetic Lignocaine Exhibits Potent Antilung Cancer Cell Activity by Inhibiting the Phosphoinositide 3-Kinases/mammalian Target of Rapamycin/Mammalian Target of Rapamycin Pathway.

Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling

PI3K/mTOR inhibitor VS-5584 combined with PLK1 inhibitor exhibits synergistic anti-cancer effects on non-small cell lung cancer

Ligustrazine Induces Apoptosis of Breast Cancer Cells in Vitro and in Vivo

Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway

Nutlin-3-induced Sensitization of Non-Small Cell Lung Cancer Stem Cells to Axitinib-Induced Apoptosis through Repression of Akt1/Wnt Signaling.

P3.02b-123 Lysimachia Capillipes Capilliposide Inhibits AKT Activation and Restores Sensitivity to Gefitinib in NSCLC with Acquired Gefitinib Resistance